Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 17;9(1):601-604.
doi: 10.1080/22221751.2020.1739565. eCollection 2020.

Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26

Affiliations

Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26

Naveen Vankadari et al. Emerg Microbes Infect. .

Abstract

The recent outbreak of pneumonia-causing COVID-19 in China is an urgent global public health issue with an increase in mortality and morbidity. Here we report our modelled homo-trimer structure of COVID-19 spike glycoprotein in both closed (ligand-free) and open (ligand-bound) conformation, which is involved in host cell adhesion. We also predict the unique N- and O-linked glycosylation sites of spike glycoprotein that distinguish it from the SARS and underlines shielding and camouflage of COVID-19 from the host the defence system. Furthermore, our study also highlights the key finding that the S1 domain of COVID-19 spike glycoprotein potentially interacts with the human CD26, a key immunoregulatory factor for hijacking and virulence. These findings accentuate the unique features of COVID-19 and assist in the development of new therapeutics.

Keywords: CD26; Coronavirus; docking; glycosylation; spike glycoprotein.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Overall homo-trimer model structure of the COVID-19 spike glycoprotein (A) ligand unbound conformation (B) ligand-bound conformation. The three protomers are coloured pink, green and cyan. S1- and S2- domains labelled. Receptor-binding induced hinge motion of S1 is distinguishable. (C) Predicted Glycan shield (spheres) of COVID-19 (green) and SARS-CoV (blue) spike glycoproteins. predicted 3C-like proteinase cleavage site (yellow). Predicted N-linked glycosylation sites for COVID-19 (D) and SARS-CoV (E). Unique glycosylation sites are coloured in Blue, and shared sites are shaded in Red.
Figure 2.
Figure 2.
(A and B) Ribbon and a surface diagram showing the docking interface of modelled COVID-19 (grey) and human CD26 (orange)(PDB: 4QZV) complex. Predicted key residues involved in the interaction are shown in sticks (CD26 residues are underlined) (C) Overall docking results showing the surface model of CD26 with COVID-19 predicted homo-trimer structure (ligand-bound conformation).

References

    1. Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5 - DOI - PMC - PubMed
    1. Lu H, Stratton CW, Tang YW.. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402. doi: 10.1002/jmv.25678 - DOI - PMC - PubMed
    1. Xiong XL, Tortorici MA, Snijder J, et al. . Glycan shield and fusion activation of a deltacoronavirus spike glycoprotein fine-tuned for enteric infections. J Virol. 2018;92(4):e01628–17. - PMC - PubMed
    1. Song WF, Gui M, Wang X, et al. . Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 2018;14(8):e1007236. doi: 10.1371/journal.ppat.1007236 - DOI - PMC - PubMed
    1. Millet JK, Kien F, Cheung C-Y, et al. . Ezrin interacts with the SARS coronavirus spike protein and restrains infection at the entry stage. Plos One. 2012;7(11): e49566. doi: 10.1371/journal.pone.0049566 - DOI - PMC - PubMed

MeSH terms